Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric mucus is a viscous secretion composed primarily of glycoproteins called mucins—mainly derived from mucous neck cells—which forms a thick layer over the gastric epithelium[3][7][8]. Its main functions are protecting the stomach lining from corrosive gastric acid and digestive enzymes by acting as a physical and pH buffer barrier and lubricating the food bolus for effective digestion and transit[1][3][7][8]. The mucus gel traps bicarbonate ions at the epithelial surface, maintaining a neutral microenvironment even as the gastric lumen remains highly acidic[3]. Disruption of the mucus barrier is implicated in peptic ulcers, gastritis, and certain forms of gastric cancer[2][3][6]; enhancement of mucus integrity is a pharmacological goal in gastric protective therapy.
Enhanced mucus secretion and cytoprotection (misoprostol, sucralfate) Acid inhibition (PPIs reduce the need for extreme mucus protection) Disruption of mucus biosynthesis (NSAIDs block prostaglandin-mediated mucus secretion)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric mucus.